Misonix, Inc.

(NasdaqGM: MSON), a medical device company that designs, manufactures and markets innovative therapeutic ultrasonic products worldwide for wound debridement, spine surgery, cosmetic surgery, neurosurgery, laparoscopic surgery and other surgical applications, has entered into a new government services partnership agreement with Technical Communities, Inc.

The agreement authorizes Technical Communities to distribute the following Misonix products to federal government institutions: -- SonicOne@ - an innovative, ultrasonic wound cleansing and debridement system -- Hyalomatrix@ - an advanced "skin substitute" for non-healing wounds and burns -- SOMAT - a hypochlorous acid based wound therapy solution -- BoneScalpelT - a novel ultrasonic bone cutting system for rapid, safe and precise osteotomies -- SonaStar@ - a state-of-the-art, ultrasonic aspiration system for soft and hard tissue Located in California's Silicon Valley and the Washington DC corridor, Technical Communities serves more than 1,200 government and contractor buying organizations through its innovative online technology marketplaces and an extensive government-focused content network. With more than 12 years of experience in growing sales for its partners that sell to U.S. government agencies, prime federal contractors, state and local governments and educational organizations, Technical Communities is one of the fastest growing suppliers of technical solutions to the U.S. government.

"We are pleased to partner with Technical Communities in the very important government sector of healthcare product sales, said Michael A. McManus, Jr., President and Chief Executive Officer of Misonix.

"We are particularly pleased that they will be marketing and selling our portfolio of advanced wound care products, as well as our flagship surgical products." "Technical Communities is looking forward to working with Misonix and to further expanding our service in the medical device market," said Peter Ostrow, President and CEO of Technical Communities.  "With Technical Communities' expertise in the federal market, we are committed to help Misonix achieve greater reach into government purchasing organizations." Misonix products will be offered under General Services Administration (GSA) Schedule Contract V797-4410B and under the Department of Veterans Affairs federal Supply Schedule (VA FSS) 6511A, managed by Technical Communities.  Technical Communities will provide Misonix with sales support, demand generation, marketing and reporting services.  Misonix products will be available through Technical Communities' online marketplaces and, as well as through the GSA's e-commerce website

About Misonix Misonix, Inc. designs, develops, manufactures and markets therapeutic ultrasonic medical devices. Misonix's therapeutic ultrasonic platform is the basis for several innovative medical technologies. Addressing a combined market estimated to be in excess of $3 billion annually; Misonix's proprietary ultrasonic medical devices are used for wound debridement, cosmetic surgery, neurosurgery, laparoscopic surgery, and other surgical and medical applications. Additional information is available on the Company's Web site at

About Technical Communities Companies who sell to the government rely on Technical Communities for proven go-to-market solutions to grow sales, lower costs and reduce risks.  With more than 12 years of public sector contract management, sales and marketing experience and with the largest proprietary database for government technical procurement, Technical Communities is one of the fastest growing suppliers of technical solutions to the U.S. government.  Technical Communities has offices in California's Silicon Valley and the Washington, DC area.  The company is the owner and operator of marketplaces,,,, and government business and procurement content network including

For more information, visit

Safe Harbor Statement With the exception of historical information contained in this press release, content herein may contain "forward looking statements" that are made pursuant to the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995. These statements are based on management's current expectations and are subject to uncertainty and changes in circumstances. Investors are cautioned that forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from the statements made.

These factors include general economic conditions, delays and risks associated with the performance of contracts, risks associated with international sales and currency fluctuations, uncertainties as a result of research and development, acceptable results from clinical studies, including publication of results and patient/procedure data with varying levels of statistical relevancy, risks involved in introducing and marketing new products, potential acquisitions, consumer and industry acceptance, litigation and/or court proceedings, including the timing and monetary requirements of such activities, the timing of finding strategic partners and implementing such relationships, regulatory risks including approval of pending and/or contemplated 510(k) filings, the ability to achieve and maintain profitability in the Company's business lines, and other factors discussed in the Company's Annual Report on Form 10-K, subsequent Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. The Company disclaims any obligation to update its forward-looking relationships.

Investor Relations Contacts Misonix Contact: Lytham Partners, LLC Richard Zaremba Robert Blum, Joe Dorame, Joe Diaz 631-694-9555 602-889-9700 SOURCE Misonix, Inc.

-0- 04/03/2012 /Web Site: (NASDAQ-NMS:MSON) / CO: Misonix, Inc.; Technical Communities, Inc.

ST: New York IN: CPR HEA MEQ HRD MTC SU: PDT LIC PRN -- LA81200 -- 0000 04/03/2012 11:30:00 EDT http://www.prnewswire.c